Eikon Therapeutics, Inc. EIKN Other long-term liabilities
Other long-term liabilities at other companies
Other financials
Where this comes from
Reported directly by Eikon Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities.
The official record: Eikon Therapeutics, Inc. ’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Eikon Therapeutics, Inc. 's other long-term liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Eikon Therapeutics, Inc. 's other long-term liabilities?
- Eikon Therapeutics, Inc. (EIKN) reported other long-term liabilities of -$311K in Q1 2025.